C07D 487/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in
Official title: Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
C07D487/00 (Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in) appears on 19,816 US grants and 23,517 published applications in this corpus.
Search patents in C07D- Granted patents
- 19,816
- Published applications
- 23,517
- Assignees
- 5,163
- Inventors
- 44,885
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 116 | 0 |
| 1977 | 87 | 0 |
| 1978 | 136 | 0 |
| 1979 | 88 | 0 |
| 1980 | 111 | 0 |
| 1981 | 116 | 0 |
| 1982 | 103 | 0 |
| 1983 | 84 | 0 |
| 1984 | 122 | 0 |
| 1985 | 121 | 0 |
| 1986 | 132 | 0 |
| 1987 | 113 | 0 |
| 1988 | 136 | 0 |
| 1989 | 165 | 0 |
| 1990 | 168 | 0 |
| 1991 | 191 | 0 |
| 1992 | 190 | 0 |
| 1993 | 198 | 0 |
| 1994 | 157 | 0 |
| 1995 | 194 | 0 |
| 1996 | 220 | 0 |
| 1997 | 296 | 0 |
| 1998 | 279 | 0 |
| 1999 | 230 | 0 |
| 2000 | 240 | 0 |
| 2001 | 260 | 42 |
| 2002 | 301 | 303 |
| 2003 | 282 | 470 |
| 2004 | 218 | 625 |
| 2005 | 290 | 593 |
| 2006 | 367 | 637 |
| 2007 | 365 | 662 |
| 2008 | 381 | 640 |
| 2009 | 427 | 797 |
| 2010 | 457 | 854 |
| 2011 | 493 | 883 |
| 2012 | 603 | 850 |
| 2013 | 776 | 922 |
| 2014 | 812 | 1042 |
| 2015 | 902 | 1075 |
| 2016 | 853 | 1081 |
| 2017 | 970 | 1111 |
| 2018 | 870 | 1123 |
| 2019 | 945 | 1175 |
| 2020 | 868 | 1235 |
| 2021 | 865 | 1150 |
| 2022 | 702 | 1185 |
| 2023 | 686 | 1571 |
| 2024 | 760 | 1360 |
| 2025 | 774 | 1232 |
| 2026 | 596 | 899 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for parasite control6 Oct 2026US 12,751,453 B2Philip Morris Products S. A.
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Double degraders and uses thereof6 Oct 2026US 12,753,172 B2Kymera Therapeutics, Inc.
- Process for the preparation of (9S)-2-bromo-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[1,5-A]azepine6 Oct 2026US 12,753,175 B2Hoffmann-La Roche Inc.
- Cdk2 inhibitor pyrazolopyrimidine compounds8 Oct 2026US 2026/0306496 A1Aleksia Therapeutics, Inc.
- Beta-elemene derivative containing photoaffinity group diazirine, and preparation method and use thereof as photoaffinity molecular probe8 Oct 2026US 2026/0308128 A1Hangzhou Normal University
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders8 Oct 2026US 2026/0308154 A1The Regents of the University of California
- Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof8 Oct 2026US 2026/0308155 A1BeOne Medicines I GmbH
Most cited
By later US patents
- OLEDs doped with phosphorescent compounds1,989US 6,303,238 B1The Trustees of Princeton University · 2001
- Process for the preparation of azabicyclo compounds1,087US 5,086,170 ARoussel Uclaf · 1992
- Pyrimidine derivatives for labeled binding partners639US 5,502,177 AGilead Sciences, Inc. · 1996
- Pyrimidine derivatives488US 6,005,096 AGilead Sciences, Inc. · 1999
- Pyrimidine derivatives for labeled binding partners456US 5,763,588 AGilead Sciences, Inc. · 1998